Progestogen deficiency and endometrial cancer risk

Maturitas - Tập 62 - Trang 334-337 - 2009
Adolf E. Schindler1
1Institut für Medical Research and Education, Hufelandstr. 55, 45122 Essen, Germany

Tài liệu tham khảo

Weiterpass, 2000, Body size in different periods of life, diabetes mellitus, hypertension and risk of postmenopausal and endometrial cancer, Cancer Causes Control, 11, 185, 10.1023/A:1008946825313

Sherman Me, 2007, Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones, Gynecol Oncol, 107, 431, 10.1016/j.ygyno.2007.07.061

Xu, 2004, Menstrual and reproductive factors and endometrial cancer risk: Results from a population-based case–control study in urban Shanghai, Int. J. Cancer, 108, 613, 10.1002/ijc.11598

Wernli, 2006, Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women, Cancer Causes Control, 17, 949, 10.1007/s10552-006-0034-6

Garrett, 2008, Hormonal therapies and gynaecological cancers, Best Practice Res Clin Obstet Gynecol, 22, 407, 10.1016/j.bpobgyn.2007.08.003

Davies, 2004, Immunomodulatory and transcriptional effects of progesterone through progesterone A and B receptors in Hec50co poorly differentiated endometrial cancer cells, J Soc Gynecol Invest, 11, 494, 10.1016/j.jsgi.2004.04.003

Maxwell, 2006, Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk, Gynecol Oncol, 103, 535, 10.1016/j.ygyno.2006.03.046

Grady, 1995, Hormone replacement therapy and endometrial cancer risk: a metaanalysis, Obstet Gynecol, 85, 304, 10.1016/0029-7844(94)00383-O

Lacey, 2005, Endometrial carcinoma risks among menopausal estrogen plus progestogen and unopposed estrogen users in a cohort of postmenopausal women, Cancer Epidemiol Biomarkers Prev, 14, 1724, 10.1158/1055-9965.EPI-05-0111

Strom, 2006, Case control study of postmenopausal hormone replacement therapy and endometrial cancer, Am J Epidemiol, 164, 775, 10.1093/aje/kwj316

Chuback, 2007, Endometrial cancer risk in estrogen users after switching to estrogen-progestin therapy, Cancer Causes Control, 18, 1001, 10.1007/s10552-007-9040-6

Mizunuma, 2001, Postmenopausal hormone replacement therapy use and risk of endometrial cancer in Japanese women, Climacteric, 4, 293, 10.1080/cmt.4.4.293.298

Doherty, 2007, Long-term use of postmenopausal estrogen and progestin hormonal replacement therapy and the risk of endometrial cancer, Obstet Gynecol, 197, 139

Roussouw, 2002, Risks and benefits of estrogen plus progestin in healthy post menopausal women: principal results from the Women's Health Initiative randomized controlled trial, JAMA, 288, 321, 10.1001/jama.288.3.321

Schindler AE Medikamtentöse Therapie. In: Schindler AE (Ed.), Gutartige Proliferative Erkrankungen der Frau. Bücherei des Frauenarztes, vol. 40. Stuttgart: Enke; 1991. p. 50–86.

Lai, 2006, The role of hormones for the treatment of endometrial hyperplasia and endometrial cancer, Curr Opin Obstet Gynecol, 18, 29, 10.1097/01.gco.0000192994.37965.c6

Schindler, 2001, Progestins and endometrial cancer, Gynecol Endocrinol, 15, 29, 10.1080/gye.15.s6.29.36

Thông tin
Thông tin xuất bản

Maturitas

Tập 62

334-337

Thông tin tác giả